RedChip Companies
|
Weekly Newsletter
|
|
|
|
Medalist Diversified REIT, Inc. Announces Cash Dividend of $0.02 Per Share on Its Common Stock
|
|
Medalist Diversified REIT (NASDAQ: MDRR), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing commercial real estate in the Southeast region of the U.S., announced that its Board of Directors has authorized and the Company has declared a quarterly cash dividend on its common stock in the amount of $0.02 per share.
The Q2 2022 dividend will be payable in cash on July 21, 2022 to holders of record of the Common Stock as of July 18, 2022. Thomas Messier, CEO and Chairman, said, “The declaration of the common stock dividend by our board of directors demonstrates their continued confidence in the company’s operating cash flow and the underlying strength of our portfolio.”
Medalist Diversified REIT Inc. is a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Mid-Atlantic and Southeast regions. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions.
For more information, visit www.medalistreit.com
|
Medigus: Eventer Signs Agreements with Two Teams from the Israeli Basketball Premier League and the Israeli National Basketball League
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that Eventer Technologies Ltd., a software company operating events and virtual events sector, 47.69% owned by Medigus, signed agreements with two basketball teams from the Israeli Basketball Premier League and the Israeli National Basketball League. As part of the agreements, Eventer will sell tickets for the teams’ games.
|
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that it has successfully completed the development of its top-tier drug candidate SCI-110 to be used in its upcoming multinational, multicenter, Phase IIb study for Tourette Syndrome. The Company recently announced that it has received ethics committee approvals from Hannover Medical School in Hannover, Germany, and the Tel Aviv Sourasky Medical Center, in Tel Aviv, Israel. SCI-110 is developed and manufactured by Procaps Group S.A., a leader in contract development and manufacturing services in soft-gel advanced technologies for the global pharmaceutical industry.
|
|
|
EV Technology Group Company, MOKE France, Partners With GOMECANO to Offer On-Demand After-Sales Services to All Electric MOKE Drivers in France
EV Technology Group Ltd.(NEO: EVTG, DE: B96A) announced that its wholly owned subsidiary MOKE France SAS has partnered with GOMECANO, a company offering on-demand mobile mechanics to perform automotive repairs. MOKE France’s partnership with GOMECANO offers Electric MOKE owners the opportunity to have access to on-demand mechanics for vehicle repairs in just a few simple steps, from the comfort of their home or office. The nationally recognized on-demand vehicle servicing company offers high-end customer service and has many highly qualified mechanics, making GOMECANO the perfect partner for keeping the Electric MOKE vehicles on the road, for general maintenance and any required repair.
|
Siyata’s Next Generation Push-to-Talk Over Cellular SD7 Device is Now Commercially Available and Sold Through FirstNet(R) and AT&T Inc.
Siyata Mobile Inc. (NASDAQ:SYTA/SYTAW), a global vendor of Push-to-Talk over Cellular devices and cellular signal booster systems, announced that the company’s SD7 rugged device is now commercially available on and will be sold through the FirstNet® network and to AT&T Inc.'s enterprise channels. AT&T is one of America's largest mobile operators with 201.8 million mobility subscribers, as of Q4 2021. As a Siyata channel partner, AT&T will offer the SD7 device and accessories to their extensive U.S. enterprise customer base. The SD7 was developed to disrupt and replace the multi-billion-dollar Land Mobile Radio (LMR) industry and is perfectly suited for AT&T's enterprise customers who require a rugged device that can operate reliably in harsh working environments. AT&T has approximately 3 million business customers (as of Q4 2021) in verticals including: construction, energy and utility, transportation and logistics, manufacturing, government & defense, travel & hospitality.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: DPRO - Draganfly |
4:15pm Eastern |
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
4:15pm Eastern |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: SVFD - Save Foods |
4:15pm Eastern |
Save Foods Inc and its Israeli subsidiary Save Foods Ltd are innovative, dynamic companies dedicated to delivering integrated eco-friendly solutions for improved safety, freshness and quality, every step of the way from field to fork. |
|
|
|
|
OTC: ODYY - Odyssey Health Inc |
11:00am Eastern |
Odyssey Health Inc. (formerly Odyssey Group International, Inc.) is a technology and asset acquisition company with a focus in the area of life saving medical solutions. |
|
|
Archive Events |
|
|
|
NASDAQ: RNAZ - TransCode Therapeutic |
Meeting Duration 46 minutes |
TransCode Therapeutics is developing therapeutic and diagnostic candidates designed to deliver on the promise of RNA in oncology. |
|
|
|
|
Private - Newt Financial |
Meeting Duration 47 minutes |
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. |
|
|
|
|
NYSE American: GNS - Genius Group |
Meeting Duration 28 minutes |
Genius Group is the holding company for GeniusU, Genius Institute and Genius School. GeniusU is an edtech platform providing over 2.6 million students across 200 countries with personalized learning paths and micro-degrees on business building skills. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 45 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
Lesson of the Week
Find stocks that the pack is not thinking about.
|
|
|
RedChip TV |
MidSouth Week in Review
For the week, the S&P declined 2.3%.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
|
© 2022 RedChip , All rights reserved
|
|
|
|
|
|